United States · Series D startup
5 rounds we have observed, with the 7 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$38Mraised across 5 rounds since 2006, from 5 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Reported by finsmes.comSEC filing: $8.2M sold, first sale Aug 2011
No investor was named in the report.
From a historical funding recordSEC filing: $2.0M sold, first sale Nov 2010
No investor was named in the report.
From a historical funding recordSEC filing: $3.1M sold, first sale Aug 2009
From a historical funding record
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Vivo VenturesPalo Alto Investors
Ben Franklin Technology Partners
Osage Venture Partners
BioAdvanceMissing a round, or an investor who was in one? Tell us.
Yaupon Therapeutics's investors include Vivo Ventures, Palo Alto Investors, Ben Franklin Technology Partners, Osage Venture Partners and Burrill & Company, and 2 more on record.
Yaupon Therapeutics has raised $38M across 5 rounds since 2006.
Yaupon Therapeutics's most recent round was a Series D of $14M in Aug 2011.
Yaupon Therapeutics's largest round on record is $15M (Series C), in Nov 2007.
Yaupon Therapeutics's first round on record, in Nov 2006, was backed by Ben Franklin Technology Partners, Osage Venture Partners and BioAdvance.
Yaupon Therapeutics's latest named round is a Series D, in Aug 2011.
Yaupon Therapeutics is based in the United States.
In the same sector, and raised in the last eighteen months.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States · 
